207 related articles for article (PubMed ID: 28420111)
1. Plantago asiatica L. Ameliorates Puromycin Aminonucleoside-Induced Nephrotic Syndrome by Suppressing Inflammation and Apoptosis.
Kho MC; Park JH; Han BH; Tan R; Yoon JJ; Kim HY; Ahn YM; Lee YJ; Kang DG; Lee HS
Nutrients; 2017 Apr; 9(4):. PubMed ID: 28420111
[TBL] [Abstract][Full Text] [Related]
2. Tripterygium glycoside fraction n2 ameliorates adriamycin-induced nephrotic syndrome in rats by suppressing apoptosis.
Wang XW; Tian RM; Yang YQ; Wang K; Li EN; Han XD; Bao K; Mao W; Xu HT; Liu B; Xu P
J Ethnopharmacol; 2020 Jul; 257():112789. PubMed ID: 32234597
[TBL] [Abstract][Full Text] [Related]
3. Qi-Dan Fang ameliorates adriamycin-induced nephrotic syndrome rat model by enhancing renal function and inhibiting podocyte injury.
Wu JB; Ye SF; Liang CL; Li YC; Yu YJ; Lai JM; Lin H; Zheng J; Zhou JY
J Ethnopharmacol; 2014 Feb; 151(3):1124-1132. PubMed ID: 24389029
[TBL] [Abstract][Full Text] [Related]
4. Effect of dietary antioxidants on puromycin aminonucleoside nephrotic syndrome.
Pedraza-Chaverri J; Arévalo AE; Hernández-Pando R; Larriva-Sahd J
Int J Biochem Cell Biol; 1995 Jul; 27(7):683-91. PubMed ID: 7648424
[TBL] [Abstract][Full Text] [Related]
5. Taurine Supplementation Alleviates Puromycin Aminonucleoside Damage by Modulating Endoplasmic Reticulum Stress and Mitochondrial-Related Apoptosis in Rat Kidney.
Stacchiotti A; Favero G; Lavazza A; Monsalve M; Rodella LF; Rezzani R
Nutrients; 2018 May; 10(6):. PubMed ID: 29843457
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of antithrombin on puromycin aminonucleoside nephrosis in rats.
Yamashita J; Nakajima K; Ohno Y; Kaneshiro Y; Matsuo T; Tanaka H; Kaneko K
Eur J Pharmacol; 2008 Jul; 589(1-3):239-44. PubMed ID: 18541230
[TBL] [Abstract][Full Text] [Related]
7. Yi Qi Qing Re Gao formula ameliorates puromycin aminonucleoside-induced nephrosis by suppressing inflammation and apoptosis.
Wen Y; Zhan Y; Liu H; Zhao T; Yang L; Zhang H; Dong X; Li P
BMC Complement Altern Med; 2015 May; 15():155. PubMed ID: 26014479
[TBL] [Abstract][Full Text] [Related]
8. Effect of clofibrate on fatty acid metabolism in the kidney of puromycin-induced nephrotic rats.
Muroya Y; Ito O
Clin Exp Nephrol; 2016 Dec; 20(6):862-870. PubMed ID: 26949064
[TBL] [Abstract][Full Text] [Related]
9. Sinkihwan-gamibang ameliorates puromycin aminonucleoside-induced nephrotic syndrome.
Lee HK; Jang YJ; Na SW; Kim HY; Han BH; Lee YJ; Lee HS; Yoon JJ; Kang DG
Chin J Nat Med; 2022 Mar; 20(3):177-184. PubMed ID: 35369961
[TBL] [Abstract][Full Text] [Related]
10. The lowering effect of probucol on plasma lipoprotein and proteinuria in puromycin aminonucleoside-induced nephrotic rats.
Hirano T; Mamo JC; Nagano S; Sugisaki T
Nephron; 1991; 58(1):95-100. PubMed ID: 1857487
[TBL] [Abstract][Full Text] [Related]
11. Disorder of fatty acid metabolism in the kidney of PAN-induced nephrotic rats.
Muroya Y; Ito O; Rong R; Takashima K; Ito D; Cao P; Nakamura Y; Joh K; Kohzuki M
Am J Physiol Renal Physiol; 2012 Oct; 303(7):F1070-9. PubMed ID: 22874759
[TBL] [Abstract][Full Text] [Related]
12. Plasma and urinary lipids and lipoproteins during the development of nephrotic syndrome induced in the rat by puromycin aminonucleoside.
Gherardi E; Calandra S
Biochim Biophys Acta; 1982 Feb; 710(2):188-96. PubMed ID: 7066357
[TBL] [Abstract][Full Text] [Related]
13. Dexamethasone prevents podocyte apoptosis induced by puromycin aminonucleoside: role of p53 and Bcl-2-related family proteins.
Wada T; Pippin JW; Marshall CB; Griffin SV; Shankland SJ
J Am Soc Nephrol; 2005 Sep; 16(9):2615-25. PubMed ID: 15987750
[TBL] [Abstract][Full Text] [Related]
14. Glomerular abundance of nephrin and podocin in experimental nephrotic syndrome: different effects of antiproteinuric therapies.
Nakhoul F; Ramadan R; Khankin E; Yaccob A; Kositch Z; Lewin M; Assady S; Abassi Z
Am J Physiol Renal Physiol; 2005 Oct; 289(4):F880-90. PubMed ID: 15942045
[TBL] [Abstract][Full Text] [Related]
15. Effect of indomethacin on lymphocyte response to mitogens in puromycin aminonucleoside nephrosis in the rat.
Garin EH; Barratt TM
Clin Exp Immunol; 1982 Sep; 49(3):639-44. PubMed ID: 7172499
[TBL] [Abstract][Full Text] [Related]
16. Podocyte protection by darbepoetin: preservation of the cytoskeleton and nephrin expression.
Eto N; Wada T; Inagi R; Takano H; Shimizu A; Kato H; Kurihara H; Kawachi H; Shankland SJ; Fujita T; Nangaku M
Kidney Int; 2007 Aug; 72(4):455-63. PubMed ID: 17457371
[TBL] [Abstract][Full Text] [Related]
17. Copper and zinc metabolism in aminonucleoside-induced nephrotic syndrome.
Pedraza-Chaverrí J; Torres-Rodríguez GA; Cruz C; Mainero A; Tapia E; Ibarra-Rubio ME; Silencio JL
Nephron; 1994; 66(1):87-92. PubMed ID: 8107960
[TBL] [Abstract][Full Text] [Related]
18. Failure of antioxidant therapy to attenuate interstitial disease in rats with reversible nephrotic syndrome.
Drukker A; Eddy AA
J Am Soc Nephrol; 1998 Feb; 9(2):243-51. PubMed ID: 9527400
[TBL] [Abstract][Full Text] [Related]
19. Disease Severity Correlates with Thrombotic Capacity in Experimental Nephrotic Syndrome.
Kerlin BA; Waller AP; Sharma R; Chanley MA; Nieman MT; Smoyer WE
J Am Soc Nephrol; 2015 Dec; 26(12):3009-19. PubMed ID: 25855774
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiology of experimental nephrotic syndrome induced by puromycin aminonucleoside in rats. I. The role of proteinuria, hypoproteinemia, and renin-angiotensin-aldosterone system on sodium retention.
Pedraza-Chaverrí J; Cruz C; Ibarra-Rubio ME; Chávez MT; Calleja C; Tapia E; del Carmen Uribe M; Romero L; Peña JC
Rev Invest Clin; 1990; 42(1):29-38. PubMed ID: 2236972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
